Lawyers for Luigi Mangione, who is accused of killing UnitedHealthcare’s chief executive, say Attorney General Pam Bondi ...

UnitedHealth said on Friday that audits by outside consulting firms of its health services and pharmacy benefit units would ...

The company said it has adopted 23 ongoing "action plans" to track and implement recommended improvements, all of which will ...

UnitedHealth Group (NYSE: UNH) has endured a brutal 2025, with shares down approximately 35% year-to-date. This marks the ...

UnitedHealth Group Incorporated is rated a Buy with profits recovering and the foundation set for renewed growth. Learn more ...

Based on the results, UnitedHealth Group has outlined multiple steps it plans to take to improve operations. The company's ...

UnitedHealth Group stock is a top dividend growth stock with solid returns, reliable yield, and long-term growth prospects.

Wondering if UnitedHealth Group is a bargain or a value trap at today’s price? Let us unpack what the market is really implying about this healthcare giant. After a rough stretch that has left the ...

UnitedHealth Group Inc. released the first outside reviews of its business practices — reports it commissioned that describe ...

UnitedHealth Group said Friday that the consultants it hired to audit its operations found they’re not only “robust,” but ...

UnitedHealth Group has had a tumultuous year, marred by poor performance and controversy. Eli Lilly has thrived as it's taken control of the obesity drug market. Adding context to stock valuations can ...

UnitedHealth Group Incorporated (NYSE: UNH ) is one of the stocks that Jim Cramer shared his take on. A caller asked if the ...